Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

Summary, in English

A disadvantage of prostate-specific antigen (PSA) for the early detection of prostate cancer (PCa) is that many men must be screened, biopsied, and diagnosed to prevent one death.

• Author: Pär Stattin; Andrew J Vickers; Daniel D Sjoberg; Robert Johansson; Torvald Granfors; Mattias Johansson; Kim Pettersson; Peter T Scardino; Göran Hallmans; Hans Lilja
• Department/s: Clinical Chemistry, Malmö; EpiHealth: Epidemiology for Health
• Publishing year: 2015
• Language: English
• Pages: 207-213
• Publication/Series: European Urology
• Volume: 68
• Issue: 2
• Full text: - 2 MB; Download statistics
• Links: http://www.ncbi.nlm.nih.gov/pubmed/25682340?dopt=Abstract; http://dx.doi.org/10.1016/j.eururo.2015.01.009
• Document type: Journal article
• Publisher: Elsevier
• Topic: Urology and Nephrology
• Status: Published
• Research group: Clinical Chemistry, Malmö
• ISBN/ISSN/Other: ISSN: 1873-7560